Omid Veiseh

Omid Veiseh

Directeur/Bestuurslid bij Avenge Bio, Inc.

Health Technology
Commercial Services

Oorsprong van het eerstegraads netwerk van Omid Veiseh

EntiteitType entiteitIndustrie
5
Holding Company Pharmaceuticals: Major 5
3
Holding Company Miscellaneous Commercial Services 3

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Omid Veiseh via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
ANTARES PHARMA, INC. Pharmaceuticals: Major

Paul Wotton

Chief Executive Officer

VERICEL CORPORATION Pharmaceuticals: Major

Paul Wotton

Director/Board Member

Investment Banks/Brokers

Douglas R. Carlson

Analyst-Equity

THE GOLDMAN SACHS GROUP, INC. Investment Banks/Brokers

Josh Richardson

Private Equity Investor

Investment Banks/Brokers

Scott Morenstein

Founder

COLLEGIUM PHARMACEUTICAL, INC. Pharmaceuticals: Major

Michael Heffernan

Douglas R. Carlson

Chief Executive Officer

Corporate Officer/Principal

CELATOR PHARMACEUTICALS INC Pharmaceuticals: Major

Scott Morenstein

Director/Board Member

VELOXIS PHARMACEUTICALS A/S Pharmaceuticals: Major

Paul Wotton

Michael Heffernan

Director/Board Member

Chairman

KELYNIAM GLOBAL, INC. Medical Specialties

Paul Wotton

Chief Operating Officer

University of Virginia College/University

Josh Richardson

Graduate Degree

University of Pennsylvania College/University

Scott Morenstein

Undergraduate Degree

Investment Managers

Douglas R. Carlson

Private Equity Analyst

University of London College/University

Paul Wotton

Undergraduate Degree

Trinity College (Connecticut) College/University

Douglas R. Carlson

Undergraduate Degree

University of South Florida College/University

Josh Richardson

Undergraduate Degree

Biotechnology

Scott Morenstein

Director/Board Member

OCATA THERAPEUTICS INC Pharmaceuticals: Major

Paul Wotton

Michael Heffernan

Chief Executive Officer

Chairman

Pharmaceuticals: Major

Paul Wotton

Corporate Officer/Principal

CYNATA THERAPEUTICS LIMITED Biotechnology

Paul Wotton

Director/Board Member

Lehman Brothers, Inc. /Istanbul Division/ Investment Managers

Scott Morenstein

Corporate Officer/Principal

Pharmaceuticals: Major

Douglas R. Carlson

Corporate Officer/Principal

Investment Managers

Scott Morenstein

Chief Executive Officer

Investment Managers

Scott Morenstein

Private Equity Investor

Harvard Business School College/University

Scott Morenstein

Masters Business Admin

Kingston Business School College/University

Paul Wotton

Masters Business Admin

Biotechnology

Michael Heffernan

Chairman

Biotechnology

Michael Heffernan

Chairman

SIGILON THERAPEUTICS, INC. Biotechnology

Paul Wotton

Chief Executive Officer

IKENA ONCOLOGY, INC. Biotechnology

Douglas R. Carlson

Director of Finance/CFO

Pharmaceuticals: Major

Josh Richardson

Director/Board Member

Biotechnology

Michael Heffernan

Chairman

MOLECULAR TEMPLATES, INC. Biotechnology

Scott Morenstein

Director/Board Member

Biotechnology

Scott Morenstein

Director/Board Member

SYNLOGIC, INC. Biotechnology

Michael Heffernan

Director/Board Member

Miscellaneous Commercial Services

Scott Morenstein

Director/Board Member

Biotechnology

Josh Richardson

Director/Board Member

Pharmaceuticals: Major

Scott Morenstein

Director/Board Member

Miscellaneous Commercial Services

David Yu Zhang

Founder

Financial Conglomerates

Scott Morenstein

Director/Board Member

Pharmaceuticals: Major

Michael Heffernan

Director/Board Member

Miscellaneous Commercial Services

Josh Richardson

Director/Board Member

BIOHAVEN LTD. Pharmaceuticals: Major

Michael Heffernan

Director/Board Member

Statistieken

Internationaal

Verenigde Staten 42
Verenigd Koninkrijk 4
Denemarken 3
Australië 2
Turkije 2

Sectoraal

Health Technology 31
Finance 11
Consumer Services 8
Commercial Services 4

Operationeel

Director/Board Member 51
Independent Dir/Board Member 18
Corporate Officer/Principal 13
Chief Executive Officer 12
President 9
  1. Beurs
  2. Insiders
  3. Omid Veiseh
  4. Bedrijfsconnecties
-40 % Uitzonderlijk verlengd: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU